Maeve O'Meara
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Maeve O'Meara
Earlier roles on record: Board Member at Starling Oncology, Inc. (STLN) until January 1, 2025. Starling Oncology, Inc. reported in an 8-K filed November 12, 2024 that Maeve O'Meara resigned as director, effective January 1, 2025.
“On November 8, 2024, Maeve O'Meara notified the Board of Directors of The Oncology Institute, Inc. (the "Company") of her intention to resign as a director of the Company for personal reasons, effective as of January 1, 2025 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-11-18–2025-01-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.